BioCryst Pharmaceuticals Correlations

BCRX Stock

USD 7.22 0.03 0.41%

The current 90-days correlation between BioCryst Pharmaceuticals and Aurinia Pharmaceuticals is 0.25 (i.e., Modest diversification). The correlation of BioCryst Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

BioCryst Pharmaceuticals Correlation With Market

Very weak diversification

The correlation between BioCryst Pharmaceuticals and DJI is 0.43 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding BioCryst Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with BioCryst Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioCryst Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy BioCryst Stock please use our How to Invest in BioCryst Pharmaceuticals guide.

Moving together with BioCryst Stock

0.73	VCEL	Vericel Corp Ord	Pair Corr
0.77	DRMA	Dermata Therapeutics	Pair Corr
0.79	VPRO	Viropro	Pair Corr

Moving against BioCryst Stock

0.9	RAC	Race Oncology	Pair Corr
0.83	DRUG	Bright Minds Biosciences	Pair Corr
0.8	DNTH	Dianthus Therapeutics	Pair Corr
0.77	CMB	Cambium Bio	Pair Corr
0.77	VCYT	Veracyte Sell-off Trend	Pair Corr
0.73	DMAC	DiaMedica Therapeutics	Pair Corr
0.72	VERA	Vera Therapeutics	Pair Corr
0.64	688578	Shanghai Allist Phar	Pair Corr
0.62	VALN	Valneva SE ADR	Pair Corr
0.46	EQ	Equillium	Pair Corr
0.33	JUMP	Leveljump Healthcare Corp	Pair Corr
0.85	CDIOW	Cardio Diagnostics	Pair Corr
0.83	DRTS	Alpha Tau Medical	Pair Corr
0.75	DSGN	Design Therapeutics	Pair Corr
0.73	VIVS	VivoSim Labs, Symbol Change	Pair Corr
0.69	DWTX	Dogwood Therapeutics,	Pair Corr
0.65	DTIL	Precision BioSciences	Pair Corr
0.59	DYAI	Dyadic International	Pair Corr
0.84	BSFA	BSF Enterprise Plc	Pair Corr
0.82	VTVT	vTv Therapeutics	Pair Corr
0.81	VRDN	Viridian Therapeutics	Pair Corr
0.77	VTGN	VistaGen Therapeutics	Pair Corr
0.71	EDSA	Edesa Biotech	Pair Corr
0.63	EDIT	Editas Medicine	Pair Corr

Related Correlations Analysis

	AUPH	BBIO	ANVS	DVAX	AGEN	INO	ACAD
AUPH		0.65	-0.59	-0.69	-0.84	0.72	0.41	AUPH
BBIO	0.65		-0.73	-0.73	-0.73	0.87	-0.04	BBIO
ANVS	-0.59	-0.73		0.73	0.75	-0.83	0.2	ANVS
DVAX	-0.69	-0.73	0.73		0.65	-0.81	-0.02	DVAX
AGEN	-0.84	-0.73	0.75	0.65		-0.76	-0.18	AGEN
INO	0.72	0.87	-0.83	-0.81	-0.76		0.07	INO
ACAD	0.41	-0.04	0.2	-0.02	-0.18	0.07		ACAD
	AUPH	BBIO	ANVS	DVAX	AGEN	INO	ACAD

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

INO	+ 0.87	BBIO
AGEN	+ 0.75	ANVS
DVAX	+ 0.73	ANVS
INO	+ 0.72	AUPH
BBIO	+ 0.65	AUPH
AGEN	+ 0.65	DVAX

High negative correlations

AGEN	- 0.84	AUPH
INO	- 0.83	ANVS
INO	- 0.81	DVAX
INO	- 0.76	AGEN
AGEN	- 0.73	BBIO
DVAX	- 0.73	BBIO

Risk-Adjusted Indicators

There is a big difference between BioCryst Stock performing well and BioCryst Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze BioCryst Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
AUPH	2.09	0.38	0.12	0.35	2.93	(2.71)	4.80	(2.59)	29.36
BBIO	1.82	0.29	0.12	1.37	2.09	(2.11)	3.68	(3.40)	12.56
ANVS	3.25	(0.74)	0.00	(0.21)	0.00	0.00	6.77	(7.51)	18.10
DVAX	1.66	(0.14)	0.00	(0.19)	0.00	0.00	3.52	(3.58)	9.20
AGEN	3.54	(0.52)	0.00	(0.21)	0.00	0.00	6.54	(8.67)	30.30
INO	3.49	0.99	0.28	0.45	2.96	(4.28)	8.44	(4.39)	30.78
ACAD	1.75	(0.16)	0.00	(0.07)	0.00	0.00	3.83	(3.79)	14.40

BioCryst Pharmaceuticals Corporate Management

Yarlagadda Babu	Sr. VP of Drug Discovery	Profile
Alane Barnes	VP, General Counsel and Corporate Secretary	Profile
Elliott Berger	VP Affairs	Profile
William MBBS	Chief Officer	Profile
Stephanie Angelini	Chief Officer	Profile
Michael Jones	Executive Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC